Saturday, March 31, 2012

Role of amyloid beta as sensors and protectors in Alzheimer's and other diseases explored

Here is a great dementia resource for caregivers and healthcare professionals,

You will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two

Follow Alzheimers1 on twitter

sciencecodex


Amsterdam, NL -- Alzheimer's disease is the sixth leading cause of death in the United States and the only cause of death among the top 10 in America without a way to prevent, cure or even slow its progression, according to the Alzheimer's Association. Today, 5.4 million Americans are living with the disease, and another American develops it every 69 seconds.

Unfortunately, many Alzheimer's disease drugs targeting the misfolding of the amyloid beta protein have failed clinical trials, leading some to question the validity of the amyloid hypothesis.

In upcoming issues of the Journal of Alzheimer's Disease, Dr. Ian Murray of the Texas A&M Health Science Center College of Medicine provides a new way of looking at amyloid – not only in Alzheimer's, but also in other amyloid diseases – with a hypotheses paper and separate supporting data paper.

Murray, Ph.D., assistant professor in the Department of Neuroscience and Experimental Therapeutics in the college, is one of four authors on a hypotheses paper supporting Amyloids as Sensors and Protectors (ASAP). This hypothesis incorporates both the emerging idea that amyloid is protective and the pathological amyloid hypothesis.

Amyloid senses cellular environmental stress, such as elevation of reactive metabolites and oxidative products or metals, and then misfolds. This misfolding initiates a protective cellular response in the short term. Long-term or chronic stress such as metabolic dysfunction (diabetes) would lead to the pathological consequences of amyloid misfolding (as diabetes is a risk factor for Alzheimer's).

This interesting ASAP hypothesis is supported by existing publications in the Alzheimer's disease field, as well as from several other amyloid diseases. It also explains several disparate findings in the field and suggests further experiments to test the hypothesis.

In the supporting data paper, Dr. Murray and four other authors mechanistically linked diabetes and Alzheimer's. They demonstrated the first part of the ASAP hypothesis – amyloid can detect metabolic dysfunction. Reactive metabolites, elevated during metabolic dysfunction such as diabetes, chemically modify and misfold the amyloid protein in the test tube. These metabolites play a role in chemical glycation reactions to eventually form advanced glycation end products.

Dr. Murray demonstrates, similar to previous reports, that such modifications localize to the misfolded amyloid in Alzheimer's disease.

Source: IOS Press

Thursday, March 29, 2012

Best ever Easter gifts for those with dementia

Here is a great dementia resource for caregivers and healthcare professinals,

You will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two

Follow Alzheimers1 on twitter



Choosing the right present for someone with Alzheimer’s disease or a related dementia is certain to give him/her joyful times independently or with a loved one. Here are some tips on how to pick a perfect gift.

Over 5.4 million Americans are living with dementia. Is one of them someone you know or work with? Get him/her or anyone with Alzheimer's disease an Easter gift that will keep on giving long after the holiday is gone.

Of course, person appropriate offerings are the best. This means matching a gift to a person’s interests and abilities, However, there are some presents that will make them smile no matter what.

One such gift is a book by Susan Berg called Adorable Photographs of Our Baby -- Meaningful, Mind-Stimulating Activities and More for the Memory Challenged, Their Loved Ones and Involved Professionals, This book features baby photographs that seniors with dementia love. This book shares a plethora of ideas and resources for you.
There is an activity related to hats that is most appropriate around Easter time.

If the person is a hat lover, buying him/her a new bonnet for Easter is an extraordinary idea. It will bring back fond memories of past Easters. Perhaps you can dig out some old Easter bonnets to try on as well as talk about, together, as Susan Berg suggests in her book. You could also have fun going through an old chest of clothes,


Sharing happy times and moments of joy will make both of you feel terrific. Inviting children to partake in this experience will make the time spent together even better. Berg says that dementia folks love children. This is another reason why her book is so popular with people who have Alzheimer’s disease or a related dementia.

While you have the children around, why not go through an old chest of clothes. Children love to play dress up. Dementia folks love children and reminiscing. Surely a lively discussion will ensue putting a smile on everyone’s face. Isn’t that a priceless gift?

Another gift dementia persons will fancy is a classic musical video or DVD especially for Easter. A classic movie of this type is Rogers and Hammerstein’s movie, Easter Parade. Any Roger’s and Hammerstein movie is a good choice, However matching their interests and favorite actors and actresses should simplify the gift giving process. You can even discuss some of the movies to get a better feel for the one they might like the best.

A video sing along is great for persons who has Alzheimer’s disease or another dementia. Even if they were not music lovers in the past, music is extremely therapeutic for them. Often non-verbal folks with dementia will sing along to a song that is familiar to them. Russ Carlton has a series of videos that will enchant a person with dementia.

An audio cassette or CD is another good choice. Just as with the movies, talking about songs often brings to light a good musical selection. There are some by Mitch Miller that are favorites of many. Also Broadway tunes are a preference of those with Alzheimer’s disease or a related dementia.

Especially for a lower functioning person with dementia is the gift of hand or body lotion. Any kind will do. Just be aware of any allergies or pain issues he/she might have. If he/she can tolerate it, those with a pleasant scent work well. Give him/her a relaxing hand massage talking about how good the hand massage feels, how much you love this person, and an Easter experience you both share from the past.

If you cannot afford or do not have time to get these gifts before Easter, give the gift of yourself. No matter how hard it is for you to visit a dementia person, he/she will appreciate your company even though he/she may not be able to express it. Take him/her for a walk, sing some of your favorite songs together, or share some messages of love. Just spend some quality time with a dementia person. Both of you will feel better. Do remember to be upbeat animated and excited about visiting.

A phone call or an Easter card will do if there is no way you can visit in person. At least they will know you are thinking of them. Then visit on another day.

So no matter what you do, do not forget the person with dementia this Easter because it will make you and him/her feel good. What could be better than that?

Order most of the products mentioned in the article at Amazon.com or from the artists directly

Tuesday, March 27, 2012

Alzheimer’s drug sharply criticized

McClatchy News Service |


WASHINGTON — Watching Alzheimer’s disease steal away the memory, talents and very selves of its victims is hard enough for the people who love them. But a new pill formulated by a respected pharmaceutical company and approved by the Food and Drug Administration will do little to help most patients and bring misery to some, say two medical investigators.


The drug, Aricept 23 mg, is no more effective on the whole than the disappointing ones already on the market — but is more likely to cause gastrointestinal problems, wrote Drs. Steven Woloshin and Lisa Schwartz of Dartmouth Medical College in an article published Thursday in the medical journal BMW


The new formulation was devised to serve commercial objectives, they say, and was approved despite a poor showing in company-sponsored tests.


Woloshin and Schwartz described Aricept 23’s march to market in 2010 as “perplexing” and “depressing” and wrote “there is no excuse for manipulating vulnerable patients, desperate family members and their doctors to use a product that is most likely to cause net harm.”


Dr. Marcia Angell, former editor of the New England Journal of Medicine and author of “The Truth About the Drug Companies,” said the critique was important. “It illustrates very well how drug companies exaggerate the benefits of their drugs, minimize the side effects, and through misleading marketing to both doctors and the public convince them that a new version of a drug, with a new patent, is better than the old one, whose patent has expired,” Angell told the Los Angeles Times.


Not really a new solution


In 2010, the FDA and the pharmaceutical giant Eisai handed caregivers of those with Alzheimer’s a new option for treating their loved ones — a 23-milligram dose of the long-available Alzheimer’s drug donepezil, better known by its commercial name, Aricept.
Aricept 23 was aggressively marketed (Eisai’s marketing partner in the United States is Pfizer Inc.) in magazine advertisements in a campaign touting clinical benefits and plucking at caregivers’ heartstrings.


But Schwartz and Woloshin say the new option was a commercial plan to extend a brand-name medication’s profit-making life by t
three years.


Renewing profitability


The practice, a common response to a drug company’s imminent loss of patent rights on a product, is known as “evergreening.” Aricept’s patent rights were due to expire in November 2010, and generic drug manufacturers in short order were sure to market donepezil much more cheaply.


Pharmaceutical companies routinely look for ways — all perfectly legal — to extend the profit-making life of their product: They make a slight change to a drug’s formula or dosage, or they combine it with another drug. With FDA approval, the new product is granted three years of legal protection from generic competition.
In the case of Aricept, developing a 23-milligram tablet created a dose that couldn’t be reproduced by any combination of Aricept’s existing 5- and 10-milligram pills, making the product new enough to win a three-year reprieve from low-cost competitors.
But Woloshin and Schwartz noted Eisai’s research showed that the pill offered a greater risk of side effects such as nausea and vomiting with no proof of benefit that a caregiver would be likely to notice.


FDA officials should not have allowed it, the authors said, because the clinical studies Eisai offered in support of its application did not meet standards the agency itself had laid out.


© 2012 Herald and News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Sunday, March 25, 2012

Alzheimer’s breakthroughs revealed

Here is a great dementia resource for caregivers and healthcare professionals,

You will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two

Follow Alzheimers1 on twitter

Agedcareinsights

Sydney conference hears of significant research results which could lead to new diagnostic and therapeutic approach to the disease

Australian researchers have outlined new approaches for the diagnosis and treatment of Alzheimer's disease, which could result in accurate identification of the disease before more debilitating symptoms arise.

The diagnosis of Alzheimer’s is currently only possible through post-mortem examination of the brain, yet early diagnosis is paramount to preventing the disease from causing widespread damage to the brain.

Speaking at The Royal College of Pathologists of Australasia (RCPA) 11th annual Pathology Update conference in Sydney, two teams of scientists announced the results of extensive research which found a range of possible “biomarkers” which could result in a new diagnostic and therapeutic approach to tackling the disease.

Dr Simon Laws, from Edith Cowan University and the Australian Imaging Biomarker and Lifestyle (AIBL) research group, announced two major findings from his studies.

In the first, Laws identified a panel of eight potential plasma biomarkers for the disease.

The second study found that sex hormone levels, especially testosterone and luteinizing hormone, correlated with the presence of Alzheimer’s causing plasma and cerebral amyloid-beta in the brain, which could lead to new methods of diagnosis and treatment.

Laws said the identification and validation of a short panel of biomarkers has significant implications for the future diagnosis, prediction and monitoring of Alzheimer’s disease.

"The close association of hormones with Alzheimer’s pathology has significant implications on future treatments of the disease, with a clinical trial being the next stage in assessing the efficacy of this approach," Laws said in a statement.

The second team, led by Dr Ashley Bush of the Department of Pathology and Mental Health Research Institute at the University of Melbourne, was examining how impairments to the brain's ability to export concentrations of transition metals, like zinc, copper and iron, correlate with the presence and formation of plaques. This could provide pathologists with new methods of diagnosis and treatment of Alzheimer’s.

The levels of these ions in the brain rise with ageing and rise even more as the symptoms of Alzheimer’s set in. The abnormal regulation of metals in the brain is key to the formation of Alzheimer’s causing plaques and tau.

"These recent discoveries concerning the metal-centred neuropathology of Alzheimer’s are the target for a new class of drugs which have shown considerable promise in clinical trials. These abnormalities are also reflected in the periphery in Alzheimer’s disease and may be the basis for predictive biomarkers," said Bush.

Friday, March 23, 2012

Lifelong learning may be the best defense against Alzheimer’s disease

Here is a great dementia resource for caregivers and healthcare professionals,

You will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two

Follow Alzheimers1 on twitter

By TIMI GUSTAFSON
Covington Reporter Columnist

Exercising the brain as much as exercising the body to keep both fit and healthy has become the new mantra for the aging baby boomer generation. Scientists seem to agree. Studies show that people who were cognitively active throughout their lives are less likely to experience mental decline as they grow older.

Age-related dementia such as Alzheimer’s disease is the most feared health condition among older Americans today, second only to cancer. It is also one of the most significant health threats of the 21st century, according to a report by the Alzheimer’s Association and the Harvard School of Public Health that was first published at an international conference on the subject in Paris, France, last year.

The causes for Alzheimer’s are not yet fully understood and there are currently no effective treatments that can halt or reverse the progressively debilitating disease. Researchers have suggested that diet and exercise as well as mental stimulation may serve as preventive measures, but there is not enough scientific evidence that these have a significant impact.

There are a number of health conditions, however, believed to promote the development of dementia. One is inflammation of the brain caused by stress hormones such as cortisol, which is toxic to nerve cells in the brain and especially to those responsible for memory. Another contributing factor is cardiovascular disease because it can prevent the brain from receiving sufficient blood supply, thereby damaging it.

A more controversial suggestion is that education, or lack thereof, can make a difference in the likelihood of someone becoming demented later in life. Obviously, the notion that the well-educated have a better shot at staying mentally healthy while the unschooled run the risk of losing their minds is hard to accept because it sounds elitist and snobbish. That makes it difficult to raise the issue without provoking strong reactions. Still, we have to look at the evidence.

Neuroscientists say that the reason why education can help prevent or at least slow down an aging person’s cognitive decline is that during learning processes structural changes in the brain’s neural network take place as neurons connect with one another. This is only possible because the central nervous system is in constant dynamic flux, which enables it to respond and adapt to changing requirements.

The more learning experiences we undergo over the years, the more neural connections we develop in the brain. This does not only happen when we learn something brand new – like a foreign language or a computer program – but even when we do routine work or play our favorite games. The already established neural connections just multiply as we repeat similar mental processes. That is why most tasks become easier to master over time, which is what learning is. This process is called “neural redundancy,” meaning that many neural connections become redundant through repetition – but not obsolete because when some connections get damaged or degenerate, others take over and continue to function in their place. In other words, the more “redundant” connections we develop over a lifetime through constant learning, the less likely we will lose our skills and abilities as we age.

So the question arises whether we can avoid the decline of our mental capacities by, let’s say, learning Mandarin, reading philosophical books or mastering programming software? Not if you start late, scientists say. Being mentally active from early on and throughout life, not just when you reach old age, is what makes the difference, according to Dr. William Jagust, a professor of public health and neuroscience at the University of California at Berkeley. What you do at 40 or 50 is more important than what you take on at 75.

“Older people seem to have less efficient brains [than younger people] and have to work their brains harder,” said Dr. Jagust in an interview on the subject with the New York Times. “People who stay cognitively active may be able to use their brains more efficiently,” he added.

Does it then still make sense to strive for mental fitness when you are already approaching retirement age or even later? Within limits, yes, Dr. Jagust agrees. Memory usually diminishes with age, even with people who do not have dementia, he said. It’s more about preserving the abilities you have than acquiring new ones, although both go hand in hand.

For those looking for learning opportunities in their later years, there is no shortage of programs offered by universities and colleges throughout the country. And these are not the only options. Educational travel programs are becoming extremely popular among retirees and the travel industry is more than happy to accommodate them.

Thursday, March 22, 2012

WOMENS BOXING

Guest post of the week by Brittany Booker

I recently upgraded our television package by logging onto http://www.giveadish.com/. I added a television in our bedroom. I was surprised when I was watching the news getting ready the other day and I saw a news special on one of my students that I teach. It was a story highlighting her and a sport that she participates in that is a traditional male sport. She is involved in female boxing, which is making its debut at the summer Olympics this year in 2012. It was an ad that said they were going to air the full story in the evening. I made sure that I watched it and was really impressed with my student. She had been into boxing for the last five years. She was also involved in rallying to have women’s boxing become an Olympic sport. Of course, she wasn’t trying to make it to the Olympics, but loves the sport and encourages other young women to participate in it. What I didn’t know is that women who are female boxers still wear skirts in the ring!

Wednesday, March 21, 2012

Can Vitamin D3 in Combination with This Spice Reverse Alzheimer’s Disease Progression?

Here is a great dementia resource for caregivers and healthcare professionals,

You will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care professionals to get an easyceu or two

Follow Alzheimers1 on twitter

Health News

Patients with Alzheimer's disease tend to suffer from brain amyloidosis, a condition related to defective clearance of amyloid-beta in their brains by their innate immune system.

In order to improve the innate immune system of Alzheimer’s patients, researchers looked at the immune stimulation effects of vitamin D3 in combination with curcumin, an active compound found in the spice turmeric.

According to the study, as reported by Green Med Info:

“[Vitamin D3] is a promising hormone for [Alheimer’s] immunoprophylaxis because in Type I macrophages combined treatment with ... D3 and curcuminoids has additive effects, and in Type II macrophages ... D3 treatment is effective alone.”
Blog Flux Directory
alzheimersideas - whereIstand.com

Fitness is important in dementia prevention. Click below for more info